| 產品名稱 |
pKS300[MZ1] |
| 商品貨號 |
B226753 |
| Designations |
pKS300[MZ1] |
| Species |
Human T-lymphotropic virus 1, Human T-lymphotropic virus 1 |
| Depositors |
National Cancer Institute/FCRF, TS Papas, National Cancer Institute/FCRF |
| Vector |
DESCRIPTION OF VECTOR COMPONENT:
Name of vector: unknown
Intact vector size:
Type of vector: plasmid
Vector end: HindIII
Vector end: HindIII
Cloning sites:
Polylinker sites:
Host range: Escherichia coli
Features (with orientation and position when available):
marker(s): ampR
Cross references: |
| Insert |
DNA: cDNA DESCRIPTION OF INSERT COMPONENT:
Genome: human T-cell lymphotropic retrovirus type 1
Gene symbol: gp46(env)
Gene name: glycoprotein (viral envelope)
Contains complete coding sequence?: N
Type of DNA: dsDNA
Insert 5' end: Modification: HindIII linkers
Insert 3' end: Modification: HindIII linkers
Insert size (kb): 0.321
Cross references: Insert lengths(kb): 0.3210000097751617 Gene product: glycoprotein (viral envelope) [gp46(env)] |
| Insert Size (kb) |
0.321 |
| Media |
ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin
|
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Classification |
Retroviridae, Gamma retrovirus, Avian virus group |
| References |
Papas TS, et al. Production of human T-cell leukemia (lymphotropic) retrovirus (HTLV-1) envelope protein fragments in bacteria and use in seroepidemiological studies. US Patent 5,510,238 dated Apr 23 1996
|
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
